Skip to main content

David Martinez Selva

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

David Martinez Selva

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

DESARROLLO DE EDL6D, UN PÉPTIDO MIMÉTICO DE SHBG PARA EL TRATAMIENTO DE LA ENFERMEDAD DEL HÍGADO GRASO NO ALCOHÓLICO (NAFLD) Y LA ESTEATOHEPATITIS NO ALCOHÓLICA (NASH)

IP: David Martinez Selva
Collaborators: Lidia Fuertes Rioja
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 370568
Reference: CPP2022-009831
Duration: 01/07/2023 - 30/09/2026

Ministerio de Ciencia

DESARROLLO DE EDL6D, UN PÉPTIDO MIMÉTICO DE SHBG PARA EL TRATAMIENTO DE LA ENFERMEDAD DEL HÍGADO GRASO NO ALCOHÓLICO (NAFLD) Y LA ESTEATOHEPATITIS NO ALCOHÓLICA (NASH)

IP: David Martinez Selva
Collaborators: Lidia Fuertes Rioja
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 370568
Reference: CPP2022-009831
Duration: 01/07/2023 - 30/06/2026

Ministerio de Ciencia

Funciones Alternativas de la Sex Hormone-Binding Globulin: Mecanismos Moleculares y Papel en Fisiología y Fisiopatología

IP: David Martinez Selva
Collaborators: Maria Teresa Salcedo Allende, Lorena Ramos Pérez, Pablo Gabriel Medina, Pilar Costa Forner
Funding agency: Instituto de Salud Carlos III
Funding: 190000
Reference: PI23/00544
Duration: 01/01/2024 - 31/12/2026

New Biomarker for NAFLD and NASH Development and Progression

IP: David Martinez Selva
Collaborators: -
Funding agency: Fundació "La Caixa"
Funding: 50000
Reference: CAIXAIMPULSE/CI23-10154
Duration: 12/12/2023 - 11/08/2026

Related news

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The document provides recommendations for identifying people who are candidates for these treatments and for guiding their implementation and follow-up in clinical practice.

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.

Related professionals

Carlos Hobeich Naya

Carlos Hobeich Naya

Research technician
Transfusional Medicine
Read more
Aroa  Gomez  Brey

Aroa Gomez Brey

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Albert Moreno Mingorance

Albert Moreno Mingorance

Postdoctoral researcher
Microbiology
Read more
Raquel Ibarz Lopez

Raquel Ibarz Lopez

Administration and Management
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.